Argent Minerals Limited (ASX:ARD) Announces High-Grade Gold Assay Results
Argent Minerals (ASX:ARD) announces high-grade gold assay results, confirming significant gold mineralisation at Trunkey Creek Project.
Tag: Industry-Specific News
Benz Mining Corp (ASX:BNZ) Unveils High-Grade Gold Discovery at Glenburgh
Benz Mining Corp (ASX:BNZ) announces a significant high-grade gold discovery at Glenburgh, validating its targeting model and expanding exploration potential.
Blackstone Minerals Limited (ASX:BSX) Unlocks High Grade Copper-Gold at Mankayan
Blackstone Minerals (ASX:BSX) reports significant copper-gold assay results from drillhole BRC-60, reinforcing the potential of its Mankayan project.
AusQuest Limited (ASX:AQD) Commences Major Drilling Program
AusQuest Limited (ASX:AQD) launches a ~7,000m drilling program at its Balladonia Project in WA to test multiple base metal targets.
Breville Group Limited (ASX:BRG) Announces Response to US Tariffs
Breville Group Limited (ASX:BRG) outlines strategies to mitigate the impact of new US tariffs, maintaining its FY25 EBIT growth guidance.
Green Technology Metals (ASX:GT1) Enhances Lithium Resources at Root Project
Green Technology Metals (ASX:GT1) reports a 38% increase in Root Project’s lithium resources, reinforcing its position in Ontario’s lithium market.
Echo IQ (ASX:EIQ) Partners with Mayo Clinic Platform, Advances EchoSolv HF towards FDA Clearance
Echo IQ (ASX:EIQ) partners with Mayo Clinic Platform to advance EchoSolv HF and progress towards FDA clearance for its heart failure solution.
Cann Group Limited (ASX:CAN) Executes Supply Agreements with Chemist Warehouse
Cann Group Limited (ASX:CAN) signs supply agreements with Queensland’s Chemist Warehouse outlets to distribute its medicinal cannabis products.
Race Oncology (ASX:RAC) Activates First Australian Clinical Site for RC220 Trial
Race Oncology (ASX:RAC) initiates its first Australian clinical site for the Phase 1 RC220 trial, marking a significant step in advancing cancer treatment.
Bioxyne Limited (ASX:BXN) Signs Exclusive $7M Agreement with NectarTek
Bioxyne Limited (ASX:BXN) secures a $7 million manufacturing agreement with NectarTek, significantly increasing FY2026 revenue projections.